TWiV 959: Clinical update with Dr. Daniel Griffin

Published: Dec. 3, 2022, 5 a.m.

In his weekly clinical update Dr. Griffin\xa0discusses\xa0effectiveness of influenza vaccination of pregnant women for prevention of maternal and early infant Influenza-associated hospitalizations in South Africa,\xa0a multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes,\xa0single and 2-dose vaccinations with modified vaccinia Ankara-Bavarian Nordic induce durable B cell memory responses comparable to replicating smallpox vaccines,\xa0whether the risk of still and preterm birth is affected by the timing of symptomatic SARS-CoV-2 infection during pregnancy,\xa0medical masks versus N95 respirators for preventing COVID-19 among health care workers,\xa0alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants,\xa0real-world evidence of novel treatments for COVID-19 on mortality: a nationwide comparative cohort study of hospitalized patients in the 1st, 2nd, 3rdand 4th\xa0wave in the Netherlands,\xa0and effectiveness and safety of extended thromboprophylaxis in post-discharge patients with COVID-19.

Subscribe (free):\xa0Apple Podcasts,\xa0Google Podcasts,\xa0RSS,\xa0email

Become a\xa0patron\xa0of\xa0TWiV!

Links for this episode

Intro music is by\xa0Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv